BTMD · NASDAQ
biote (BTMD) Stock Price & Fundamentals
biote (BTMD) closed at $243.96 on Oct 9, 2026, down 0.67% from the previous close of $245.60.
Share price, past year
1Y +17.99%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $243.96 |
| Sep 30, 2026 | $243.66 |
| Aug 31, 2026 | $228.24 |
| Jul 31, 2026 | $216.78 |
| Jun 30, 2026 | $223.45 |
| May 29, 2026 | $238.05 |
| Apr 30, 2026 | $241.97 |
| Mar 31, 2026 | $223.37 |
| Feb 27, 2026 | $217.18 |
| Jan 30, 2026 | $207.46 |
| Dec 31, 2025 | $212.86 |
| Nov 28, 2025 | $204.52 |
| Oct 31, 2025 | $201.67 |
Key statistics
- Market cap
- —
- P/E (TTM)
- 2,439.6
- EPS (TTM)
- $0.10
- Revenue (TTM)
- $183.53M
- Net income (TTM)
- $5.86M
- Shares outstanding
- 58.2M
- Dividend yield
- —
- 52-week range
- $196.33 – $247.56
Financials
biote reported revenue of $192.22M for fiscal 2025, down 2.52% from fiscal 2024.
biote earned net income of $27.05M in fiscal 2025, a net margin of 14.1%.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $192.22M | −2.5% | $27.05M | 14.1% | $0.74 | $30.18M |
| FY2024ended Dec 31, 2024 | $197.19M | +6.4% | $3.16M | 1.6% | $0.09 | $38.81M |
| FY2023ended Dec 31, 2023 | $185.36M | +12.4% | $3.32M | 1.8% | $0.13 | $26.52M |
| FY2022ended Dec 31, 2022 | $164.96M | +18.3% | −$969.00K | −0.6% | −$0.12 | −$9.49M |
| FY2021ended Dec 31, 2021 | $139.40M | — | $11.11M | 8.0% | — | $32.27M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $44.23M | −$6.56M | −$0.23 |
| Q1 FY2026ended Mar 31, 2026 | $44.94M | $2.28M | $0.06 |
| Q4 FY2025ended Dec 31, 2025 | $46.41M | $1.95M | $0.05 |
| Q3 FY2025ended Sep 30, 2025 | $47.96M | $8.19M | $0.22 |
| Q2 FY2025ended Jun 30, 2025 | $48.86M | $3.19M | $0.10 |
| Q1 FY2025ended Mar 31, 2025 | $48.99M | $13.72M | $0.37 |
| Q4 FY2024ended Dec 31, 2024 | $49.83M | $3.70M | $0.09 |
| Q3 FY2024ended Sep 30, 2024 | $51.38M | $10.70M | $0.33 |
Company profile
- Name
- biote Corp.
- Ticker
- BTMD
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Medicinal Chemicals & Botanical Products
- Headquarters
- 1875 W. Walnut Hill Ln #100, Irving, TX 75038
- Fiscal year ends
- December
- SEC CIK
- 0001819253
Recent SEC filings
- Aug 7, 2026
- Aug 5, 2026
- Jun 2, 2026
- May 18, 2026
- May 11, 2026
- May 6, 2026
- Apr 3, 2026
- Mar 13, 2026
Frequently asked questions
What is biote's stock price?
biote (BTMD) closed at $243.96 on Oct 9, 2026, down 0.67% from the previous close of $245.60.
How much revenue does biote make?
biote reported revenue of $192.22M for fiscal 2025, down 2.52% from fiscal 2024.
What is BTMD's P/E ratio?
biote's price-to-earnings ratio is 2,439.6, based on trailing twelve-month diluted EPS of $0.10.
Does biote pay a dividend?
biote's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from biote Corp.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures